Down-regulation of the receptor for advanced glycation end-products (RAGE) supports non-small cell lung carcinoma.
暂无分享,去创建一个
R. Silber | A. Simm | B. Bartling | B. Weigle | H. Hofmann
[1] R. Salto,et al. AU-rich elements in the mRNA 3'-untranslated region of the rat receptor for advanced glycation end products and their relevance to mRNA stability. , 2004, Biochemical and biophysical research communications.
[2] S. Thorgeirsson,et al. DLC-1 operates as a tumor suppressor gene in human non-small cell lung carcinomas , 2004, Oncogene.
[3] A. Schmidt,et al. S100P Stimulates Cell Proliferation and Survival via Receptor for Activated Glycation End Products (RAGE)* , 2004, Journal of Biological Chemistry.
[4] Y. Hata,et al. Receptor for advanced glycation end‐products is a marker of type I lung alveolar cells , 2004, Genes to cells : devoted to molecular & cellular mechanisms.
[5] H. Shimizu,et al. Regulation of human melanoma growth and metastasis by AGE-AGE receptor interactions. , 2004, The Journal of investigative dermatology.
[6] P. Rogalla,et al. Tissue-specific expression patterns of the RAGE receptor and its soluble forms--a result of regulated alternative splicing? , 2003, Biochimica et biophysica acta.
[7] Dipali Sharma,et al. A Novel Histone Deacetylase Inhibitor, Scriptaid, Enhances Expression of Functional Estrogen Receptor α (ER) in ER negative human breast cancer cells in combination with 5-aza 2′-deoxycytidine , 2003, Breast Cancer Research and Treatment.
[8] H. Kuniyasu,et al. Differential effects between amphoterin and advanced glycation end products on colon cancer cells , 2003, International journal of cancer.
[9] R. Donato,et al. Intracellular and extracellular roles of S100 proteins , 2003, Microscopy research and technique.
[10] S. Takasawa,et al. Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury. , 2003, The Biochemical journal.
[11] H. Huttunen,et al. Receptor for Advanced Glycation End Products (RAGE) Signaling Induces CREB-dependent Chromogranin Expression during Neuronal Differentiation* , 2002, The Journal of Biological Chemistry.
[12] J. Darnell. Transcription factors as targets for cancer therapy , 2002, Nature Reviews Cancer.
[13] R. Silber,et al. Expression of inhibitors of apoptosis (IAP) proteins in non-small cell human lung cancer , 2002, Journal of Cancer Research and Clinical Oncology.
[14] A. Ridley,et al. Receptor for advanced glycation end products-binding COOH-terminal motif of amphoterin inhibits invasive migration and metastasis. , 2002, Cancer research.
[15] T. Misteli,et al. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation , 2002, Nature.
[16] R. de Caterina,et al. Advanced Glycation End Products Activate Endothelium Through Signal-Transduction Receptor RAGE: A Mechanism for Amplification of Inflammatory Responses , 2002, Circulation.
[17] H. Yokozaki,et al. Expression of receptors for advanced glycation end‐products (RAGE) is closely associated with the invasive and metastatic activity of gastric cancer , 2002, The Journal of pathology.
[18] A. Ishikawa,et al. Induced transcriptional expression of calcium-binding protein S100A1 and S100A10 genes in human renal cell carcinoma. , 2002, Cancer letters.
[19] D. Botstein,et al. Diversity of gene expression in adenocarcinoma of the lung , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[20] Y. Kuroda,et al. Differential expression of RAGE in human pancreatic carcinoma cells. , 2001, Hepato-gastroenterology.
[21] A. Schmidt,et al. The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses. , 2001, The Journal of clinical investigation.
[22] S. Müller,et al. The double life of HMGB1 chromatin protein: architectural factor and extracellular signal , 2001 .
[23] K. Tracey,et al. Dual roles for HMGB1: DNA binding and cytokine , 2001, Journal of endotoxin research.
[24] P. Schraml,et al. A novel polymorphism in the promoter of the RAGE gene is associated with non-small cell lung cancer. , 2001, Lung cancer.
[25] H. Huttunen,et al. Coregulation of Neurite Outgrowth and Cell Survival by Amphoterin and S100 Proteins through Receptor for Advanced Glycation End Products (RAGE) Activation* , 2000, The Journal of Biological Chemistry.
[26] P. Bryant,et al. LAP proteins: what’s up with epithelia? , 2000, Nature Cell Biology.
[27] S. Kern,et al. A novel histone deacetylase inhibitor identified by high-throughput transcriptional screening of a compound library. , 2000, Cancer research.
[28] J. Mesirov,et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. , 1999, Science.
[29] K. Tracey,et al. HMG-1 as a late mediator of endotoxin lethality in mice. , 1999, Science.
[30] H. Huttunen,et al. Receptor for Advanced Glycation End Products (RAGE)-mediated Neurite Outgrowth and Activation of NF-κB Require the Cytoplasmic Domain of the Receptor but Different Downstream Signaling Pathways* , 1999, The Journal of Biological Chemistry.
[31] M. Müller,et al. Receptor for advanced glycation endproducts (RAGE) exhibits highly differential cellular and subcellular localisation in rat and human lung. , 1998, Cellular and molecular biology.
[32] P. Schraml,et al. Differential messenger RNA and protein expression of the receptor for advanced glycosylated end products in normal lung and non-small cell lung carcinoma. , 1997, Cancer research.
[33] A. Heidland,et al. Advanced glycation endproducts stimulate the MAP‐kinase pathway in tubulus cell line LLC‐PK1 , 1997, FEBS letters.
[34] A. Schmidt,et al. Characterization and Functional Analysis of the Promoter of RAGE, the Receptor for Advanced Glycation End Products* , 1997, The Journal of Biological Chemistry.
[35] C. Mountain,et al. Revisions in the International System for Staging Lung Cancer. , 1997, Chest.
[36] J. Chen,et al. The Receptor for Advanced Glycation End Products (RAGE) Is a Cellular Binding Site for Amphoterin , 1995, The Journal of Biological Chemistry.
[37] P. Schraml,et al. Identification of genes differentially expressed in normal lung and non-small cell lung carcinoma tissue. , 1994, Cancer research.
[38] Y. Zou,et al. Survey of the distribution of a newly characterized receptor for advanced glycation end products in tissues. , 1993, The American journal of pathology.
[39] K. O. Elliston,et al. Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. , 1992, The Journal of biological chemistry.
[40] P. Kruse,et al. Doubling potential, calendar time, and donor age of human diploid cells in culture. , 1973, Experimental cell research.
[41] E. Lander,et al. Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[42] S. Müller,et al. New EMBO members' review: the double life of HMGB1 chromatin protein: architectural factor and extracellular signal. , 2001, The EMBO journal.
[43] P. Kruse,et al. Doubling potential, calendar time, and senescence of human diploid cells in culture. , 1973, Experimental cell research.
[44] T. Kislinger,et al. Blockade of RAGE ± amphoterin signalling suppresses tumour growth and metastases , 2022 .